Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

BioNTech, EXMceuticals, XPhyto - Covid-19 and legalizations offer potential

In recent months, the society around the globe has been going through a process of change of deceleration and standstill. Priorities have been redefined and implemented at record speeds in many places. Covid-19 serves as a catalyst for change for many people. The reasons can b...
Mario Hose | July 15, 2020 |

Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study

Shares of Aravive Inc. are trading higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. Today, in a late-breaking oral presentation at the European Soc...
Streetwise Reports | September 30, 2019 |

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-20...
Streetwise Reports | December 12, 2019 |

Protagonist's Shares Nearly Double After Reporting Q1 Earnings and Positive Phase 2 Trial Results

Shares of Protagonist Therapeutics traded higher and reached a new 52-week high price after the company released Q1/20 financial results and positive data from its Phase 2 study of PTG-300 in patients with polycythemia vera, a type of blood cancer. After U.S...
Streetwise Reports | May 11, 2020 |

Crystal Lake Mining: Moving Forward

As my readers know, I have been following B.C. based junior exploration company Crystal Lake Mining (TSXV: CLM) (OTC: SIOCF) (FSE: SOG-FF) over the past few months. Very quickly, Crystal Lake has become an important new player in the Eskay Camp with one of the district's...
Dr. Kal Kotecha | July 17, 2019 |

Germany starts war on gold

Germans, like Indians and Chinese, love their gold - although their reasons for buying and keeping bullion are somewhat different. In China and India, gold jewelry is a status symbol - a sign of wealth and success. In Germany, owning gold bars and coins, maybe a 24-karat ...
Richard (Rick) Mills | January 24, 2020 |

Crystal Lake Mining In The News

Crystal Lake Mining Corporation ( TSXV: CLM; OTC: SIOCF; FSE: SOG-FF) (”Crystal Lake” or the “ Company ”) has reported some interesting forward-motion developments lately, including the inclusion of two...
Dr. Kal Kotecha | June 20, 2019 |

Crystal Lake Mining Site Visit

I am not a proponent of global warming, pollution and receding ice fields. But reality is that these things are unfortunately transpiring and I am hoping that humanity becomes more socially responsible and that these catastrophes come to a stop or at least slow down. There a...
Dr. Kal Kotecha | September 3, 2019 |

I do not trust the markets currently but Cole Evans is a different story.

These are perilous times with both a fast spreading virus and socioeconomic challenges. This was the theme of my talk at the newsletter writers presentation at PDAC and during my media interviews. Markets have a propensity to overshoot and over correct. Unfortunately I was r...
Dr. Kal Kotecha | March 9, 2020 |

Gratomic: Eco-conscious and On The Move

Graphite has been around for what it seems to be forever. I’m sure we all remember using a form of this naturally-occurring crystalline carbon as kids in our yellow No. 2 pencils. The popularity of this highly versatile mineral with other uses incl...
Dr. Kal Kotecha | April 22, 2021 |